False-Negative Testing for FIP1L1::PDGFRA by Fluorescence in situ Hybridization Is a Frequent Cause of Diagnostic Delay.

导出 OA

翻译打印收藏纠错

作者： Thanai,Pongdee ^[1] ; Alexis,Berry ^[2] ; Lauren,Wetzler ^[2] ; Xiaoping,Sun ^[3] ; Lauren,Thumm ^[4] ; Pryscilla,Yoon ^[2] ; Fei Li,Kuang ^[5] ; Michelle,Makiya ^[2] ; Gregory,Constantine ^[2] ; Paneez,Khoury ^[2] ; Esther,Rheinbay ^[6] ; Andrew A,Lane ^[7] ; Irina,Maric ^[3] ; Amy D,Klion ^[2]

作者单位： Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. ^[1] National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. ^[2] Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA. ^[3] Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA. ^[4] Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. ^[5] Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.;Massachussetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA. ^[6] Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.;Department of Medical Oncology, Dana-Farber Cancer Instittue, Harvard Medical School, Boston, Massachusetts, USA. ^[7]

关键词 Clinical studies Eosinophilia Myeloproliferative disorders